Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2009-02-01
Metadata
Show full item recordCitation
Auris Nasus Larynx. 2009, 36(1):46-52Abstract
OBJECTIVE: To describe the changes in the epidemiology of epiglottitis in Iceland from 1983 to 2005. METHODS: All patients with the discharge diagnosis of epiglottitis during the study years were identified and diagnosis confirmed by chart review. Main outcome measures were age, gender, month/year of diagnosis, microbiology, airway management, ICU admissions, choice of antibiotics, length of hospital stay and major complications/mortality. RESULTS: Fifty-seven patients were identified (annual incidence 0.93/100.000). The mean age was 33.3 years (1-82). Childhood epiglottitis disappeared after introduction of Haemophilus influenzae type b (Hib) vaccination in 1989 but adult disease showed non-significant increase. In the pre-vaccination era Hib was the most common organism cultured but it has not been diagnosed in Iceland since 1991 and Streptococci are now the leading cause of epiglottitis. The mean hospital stay was 5.05 nights with 51% of patients admitted to ICU. All children under 10 years and a total 30% of patients received airway intervention. Ninety percent of adults were observed without airway intervention. Major complications were rare and mortality was 0% in our series. CONCLUSION: There have been major changes in the epidemiology of epiglottitis in Iceland during the study period. Previously a childhood disease, epiglottitis has disappeared in children and is now almost exclusively found in adults. This can be attributed to widespread Hib vaccination, eliminating the major causative agent in children. The treatment of this life-threatening disease remains a challenge. Our series suggest that it is safe to observe patients with mild/moderate symptoms without airway intervention.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://www.sciencedirect.com/science/article/B6T4M-4SK59DK-1/2/83a4d44f7debb0d782353d67504e4073ae974a485f413a2113503eed53cd6c53
10.1016/j.anl.2008.03.012
Scopus Count
Collections
Related articles
- [Acute epiglottitis in Iceland from 1983-2005].
- Authors: Briem B, Thorvardarson O, Petersen H
- Issue date: 2010 Jun
- Acute epiglottitis: epidemiology, clinical presentation, management and outcome.
- Authors: Guldfred LA, Lyhne D, Becker BC
- Issue date: 2008 Aug
- Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease.
- Authors: Wood N, Menzies R, McIntyre P
- Issue date: 2005 Sep
- Epiglottitis in the Hemophilus influenzae type B vaccine era: changing trends.
- Authors: Shah RK, Roberson DW, Jones DT
- Issue date: 2004 Mar
- Changing epidemiology of life-threatening upper airway infections: the reemergence of bacterial tracheitis.
- Authors: Hopkins A, Lahiri T, Salerno R, Heath B
- Issue date: 2006 Oct